Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median.
作者信息
Chiumente Marco, Mengato Daniele, Messori Andrea
机构信息
Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italy,
Department of Hospital Pharmacy, Bolzano Central Hospital, Bolzano, Italy.
出版信息
Acta Haematol. 2020;143(6):598-599. doi: 10.1159/000505891. Epub 2020 Feb 19.
PMID:32074609
Abstract
摘要
Zotero 插件